SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alkem Laboratories informs about conference call

12 Feb 2026 Evaluate

In furtherance to its earlier intimation dated 23rd January, 2026 with regard to conference call to discuss the Q3FY26 and 9MFY26 financial results to held on Friday, February 13, 2026 at 4:00 pm. With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Alkem Laboratories has informed that a conference call to discuss the Q3FY26 and 9MFY26 financial results will now be held on Friday, February 13, 2026 at 5.00 pm. The company has enclosed the updated conference call details.

The above information is a part of company’s filings submitted to BSE. 

Alkem Laboratories Share Price

5583.70 16.00 (0.29%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×